Sana Biotechnology, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:SANA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 445.47 M361.64 M435.43 M416.89 M373.59 M Total liabilities 236.39 M239.09 M240.12 M256.01 M254.35 M Total equity 209.08 M122.56 M195.31 M160.88 M119.24 M Total liabilities & shareholders' equities 445.47 M361.64 M435.43 M416.89 M373.59 M Total debt ————— Net debt —————

News

Sana (SANA) Upgraded to Buy: Here's What You Should Know

Sana Biotechnology, Inc. (SANA) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey (NASDAQ:SANA)

H.C. Wainwright reiterates Sana Biotechnology stock buy rating

Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data

Sana Biotechnology reports 14-month data on diabetes cell therapy

Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript

TD Cowen reiterates Buy rating on Sana Biotechnology stock

Citizens reiterates Sana Biotechnology stock rating on pipeline progress

Sana Biotechnology stock price target lowered to $7 by H.C. Wainwright

Genomics Stocks That Deserve a Place in Your Portfolio in 2026